WINT — Windtree Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual balance sheet for Windtree Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	16.9	22.3	6.17	4.32	1.78
Prepaid Expenses
Total Current Assets	18.1	23.5	7.38	5.38	2.57
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.84	3.39	2.12	1.63	1.16
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	113	74.8	38	32.4	27.9
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	6.13	4.92	2.46	4	5.72
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	43.3	32.9	27.9	29	14.7
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	69.6	41.9	10	3.39	13.2
Total Liabilities & Shareholders' Equity	113	74.8	38	32.4	27.9
Total Common Shares Outstanding
Total Preferred Shares Outstanding